PANEL DISCUSSION

Funding evidence-informed policy initiatives: priorities for now and the near future


Day1

14:20–15:20 (CEST)

The session will focus on funders' perspectives and priorities for the future of the evidence-to-policy (E2P) field.

 

Why does it seem that evidence-informed decision-making is usually an “extra” in projects and not the main funding focus? In this thought-provoking session, we will delve into funders' perspectives, priorities, expectations, and collaboration strategies. Discover how we can bridge the evidence-to-policy gap and enhance the impact of funding.

The session will focus on funders' perspectives and priorities for the future of the evidence-to-policy (E2P) field. The main objectives are to understand funders' views on E2P priorities, including the E2P approach within their organizations, and to learn about their expectations from actors in the evidence ecosystem.

 

Key questions and session highlights

  • What are the top two to three funding priorities of your institution to bridge the evidence-to-policy nexus? Do you see any particular gaps/areas that are underfunded? 
  • What do you expect from the E2P community – from academics, policy-makers, the UN, NGOs, knowledge brokers, etc. – when it comes to advancements in the E2P field, collaboration, or uptake of new tools and methods?
  • What is the importance of E2P in achieving a return on investment (RoI) and measuring the impact of the funding made?

 

Moderator

Farrar-R

Jeremy Farrar

Chief Scientist, World Health Organization, Switzerland

Prior to joining WHO, Dr Farrar was Director of the Wellcome Trust. In his 9 years there, he oversaw a series of major reforms, restructuring and growth, with Wellcome now collaborating with partners around the world and focused on fundamental discovery research and three challenge areas of: infectious diseases; climate and health; and mental health, all with a commitment to ensuring that equity, diversity and inclusion are central to the science they support. Before joining Wellcome, Dr Farrar spent over 17 years as Director of the Clinical Research Unit at the Hospital for Tropical Diseases in Ho Chi Minh City in Viet Nam. His clinical and research interests have been in integrated health research across a range of infectious diseases and noncommunicable illness including emerging infections, influenza, infections of the brain, dengue, typhoid, malaria, tuberculosis, antimicrobial resistance, opportunistic infections related to HIV and stroke. Dr Farrar was the founding chair of WHO’s R&D Blueprint and the founding director of the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) that led on to the work of the RECOVERY Trial and the UK COVID-19 Genomics UK Consortium. Dr Farrar trained in neurology and infectious diseases in London, Edinburgh and Oxford in the United Kingdom and in Melbourne in Australia. He has a PhD in Immunology from the University of Oxford in the United Kingdom in partnership with the University of California in San Francisco in the United States of America.
Show less Short biography

 

 

Panelists


Montasser Kamal

Director Global Health, International Development Research Centre, Canada

Montasser is the Director for Global Health at Canada’s International Development Research Centre (IDRC), formerly the Program Leader for Maternal and Child Health, and for Health Research Partnerships. Montasser was the Deputy Director for Global Health Policy and Research at Global Affairs Canada, and Team Leader of Health Specialists, and Manager of Multilateral Health Institutions and Partnerships at CIDA. At the Regional Office of the Ford Foundation in Cairo he supported research, policy, and programming related to sexual and reproductive health and HIV/AIDS. Montasser has MD, Diploma, MSc, and PhD degrees in medicine, international development, and medical anthropology from Egypt, the UK and Canada.
Show less Short biography
Chibwana-R

Christopher Chibwana

Program Officer, Gender Equity and Governance, William and Flora Hewlett Foundation, United States of America

Chris Chibwana is a Program Officer in Gender Equity and Governance at the William and Flora Hewlett Foundation. Chris manages a portfolio of grants that aim to strengthen the effectiveness of governments in Africa and improve outcomes for all people. Chris has 15 years of experience designing, managing, and evaluating development programs. Chris joined the foundation from the Alliance for a Green Revolution in Africa headquartered in Nairobi, Kenya where he served as head of the Hub for Agricultural Policy Action, an initiative designed to help governments use data and evidence to foster the enabling environment for agriculture. Prior to that, Chris spent four years working to improve lives with data and evidence as a partner and the head of Africa for IDinsight, based in Lusaka, Zambia. In this role, he was IDinsight's primary regional representative and was responsible for realizing the organization's sector-transforming vision for the Africa region. He also served at USAID for seven years, including a year in Dhaka, Bangladesh, where he led the design of a large, multisector project to improve nutrition outcomes for women and adolescent girls in the southwest region of Bangladesh. He also worked at USAID in Malawi, where he designed and oversaw projects to support evidence-informed decision-making by the Malawi government to improve results for smallholder farmers. His work as a researcher with the International Food Policy Research Institute contributed to the body of knowledge that informed subsequent reforms to the Malawi government's agricultural input subsidy program, a key government policy to enhance food security. Chris has a master's degree in agricultural economics from Purdue University in Indiana and a bachelor's degree in agribusiness management from the University of Malawi.
Show less Short biography
Hartmann-R
Nico Herzog für VolkswagenStiftung
© Credits

Henrike Hartmann

Deputy Secretary General, Volkswagen Foundation, Germany

2021: Deputy Secretary General of the Foundation; 2015: Head of the Funding Department and Member of the Executive Board; 2010-2015: Head of the team "People and Structures" within the funding department; 1998: Transfer to the Volkswagen Foundation as specialist for biomedicine and neuroscience; 1995-1998: Postdoctoral fellow at Boston Children's Hospital, Harvard Medical School/USA and research associate in pharmacology at the University of Frankfurt. 1993: Doctorate in the field of psychopharmacology at the Central Institute for Mental Health in Mannheim/University of Heidelberg; 1984-1989: Pharmacy studies in Freiburg.
Show less Short biography

Beth Thompson

Chief Strategy Officer, Wellcome Trust, United Kingdom

Dr Beth Thompson is Wellcome’s Chief Strategy Officer, responsible for the work of the strategy and programme office, government relations and strategic partnerships, policy, and transition and legacy teams. Beth has stepped into this role from leading Wellcome’s global policy work across discovery research, mental health, infectious disease and climate. Prior to this she led UK & EU policy and advocacy activities, covering issues including Brexit and research culture. In 2017 Beth was awarded an MBE for services to science for successfully advocating against amendments to the EU General Data Protection Regulation that would have been severely damaging for research. Beth holds a PhD from the Medical Research Council Laboratory of Molecular Biology in Cambridge and a degree in Natural Sciences (Biochemistry) from the University of Cambridge.  
Show less Short biography

 

 

Surmatz-R

Hanna Surmatz

Head of Policy, Philantrophy Europe Association (Philea), Belgium

Hanna Surmatz is Head of Policy at the Philanthropy Europe Association (Philea) since 2022.  She has been working towards a favourable operating environment for foundations and philanthropy since 2004. Her main responsibilities include monitoring and mapping/analysis of sector relevant policy developments; co-ordination of benchmarking exercises; and facilitating information exchange and engagement with policymakers and academia. Between 2001 and 2004 she was employed by the Association of German Foundations. She studied law at the University Münster, Germany and at the University of Poitiers, France and worked as assistant researcher at the University of Münster for several years. Since 2017 she is the representative of the philanthropic sector in the Financial Action Task Force (FATF) Private Sector Consultative Forum (PSCF) and since 2019 in the OECD Tax Business Advisory Group. In 2021 she became a member of the European Commission expert group on Social Economy. She also represents Philea in the European Economic and Social Committee (EESC) CSO Liaison Group and together with ONCE foundation in the Social Economy Europe board.
Show less Short biography

 

 

Angela Bednarek

Project Director, The Pew Charitable Trusts, Lead of the Transforming Evidence Funders Network, United States of America

Angela Bednarek, Ph.D., directs the Evidence Project at The Pew Charitable Trusts. The project promotes innovative and participatory research and problem-solving processes that can inform equitable and effective policy and practice. She created and now leads the Transforming Evidence Funders Network, a global, cross-sectoral network of public and private funders driving change in how research and evidence are produced, mobilized and used for societal impact. She has published and presented widely on improving the connections between research, policy, and practice. She serves on the U.S. National Academy of Sciences Standing Committee on Advancing Science Communication Research and Practice, as vice-chair of the board of the Global Council for Science and the Environment, and on the Research Advisory Council for the Partnership for Public Service. Bednarek holds a doctorate in biology from the University of Pennsylvania.
Show less Short biography